Visalytics
Visalytics
approved EB-2 (NIW)

Formulation Chemist

Chemistry · Iran · 2025-06-17

Processing Time
8 days
Decision Date
2025-06-17
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance research integrating artificial intelligence and machine learning-driven in-silico methodologies with experimental chemistry. This work focuses on streamlining the discovery of next-generation active ingredients and optimizing formulation processes for pharmaceutical, cosmetic, and dermaceutical products. The endeavor aims to transition the U.S. pharmaceutical industry toward more ethical, efficient methods by reducing reliance on animal testing.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the national need for efficient pharmaceutical development and ethical alternatives to animal testing.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., extensive publication record, and 400 citations demonstrate the expertise necessary to lead this research.

3 Balance of Interests Met

The innovative nature of the AI-driven chemistry research makes it beneficial to waive the labor certification requirement to ensure the U.S. retains this specialized talent.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in chemistry and a strong record of 10 peer-reviewed journal articles (including 2 as corresponding author) and 11 conference abstracts. The evidence showed 400 citations with several papers in the top 1% of the field, as well as experience in peer review and serving as a conference session chair. These metrics satisfied all three Dhanasar prongs by demonstrating the national importance and high impact of the research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Chemist

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
Pennsylvania 364 days 2025-11-26
The petitioner proposes to develop practical and efficient synthetic routes to produce active pharmaceutical ingredients (APIs) for drugs currently in clinical trials. This work focuses on improving scalable production methods to reduce costs and shorten development timelines for new therapies targeting cancer and neurodegenerative disorders.
View Case

Machine Learning Engineer

Biotechnology · China

WeGreened EB-2 (NIW) approved
Massachusetts 22 days 2025-04-22
The petitioner proposes to develop advanced machine learning methods, cheminformatics tools, and modeling techniques to accurately predict molecular and chemical reaction properties. This work aims to accelerate the discovery of new molecules and streamline screening processes for pharmaceuticals, cosmetics, biofuels, and industrial dyes. The endeavor focuses on integrating predictive algorithms with cheminformatics models to assess novel molecules with high speed and accuracy.
View Case

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 4 days 2025-08-08
The petitioner proposes to develop and apply advanced machine learning and computational chemistry methods to predict molecular properties with high accuracy. This work focuses on the targeted design of novel molecules to accelerate drug discovery and reduce the high costs and failure rates associated with therapeutic development.
View Case

Consultant

Engineering · India

WeGreened EB-2 (NIW) approved
New Jersey 45 days 2025-01-16
The petitioner proposes to continue research on developing advanced machine learning, artificial intelligence, and language modeling frameworks by integrating data-driven methods with domain knowledge. This work aims to address key challenges in drug development and healthcare, specifically focusing on accelerating drug discovery, optimizing clinical trials, and enhancing manufacturing efficiency.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-06-17.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist